VPVenetiana Panaretou

Venetiana Panaretou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Venetiana Panaretou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Antonis Louizos

    Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece

    1 shared publication
  • Ioannis Papazoglou

    Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece

    1 shared publication
  • Irene Kouroukli

    Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece

    1 shared publication
  • Vasiliki Tsekoura

    Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece

    1 shared publication
  • Vasilios Zompolas

    Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece

    1 shared publication

Latest Publications

  • Open Access

    Comparison between lornoxicam quick-release and parecoxib for post-operative analgesia after laparoscopic cholecystectomy: A prospective randomized, placebo-controlled trial

    by Irene Kouroukli, Vasilios Zompolas, Vasiliki Tsekoura, Ioannis Papazoglou, Antonis Louizos, Venetiana Panaretou

    Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are valuable for post-operative pain as they reduce the use of opioids. Cyclooxygenase-2 inhibitors and traditional NSAIDs can be used. This is a prospective, randomized, placebo-controlled trial to study the efficacy and the safety of the oral administration of lornoxicam quick release tablets versus intravenously administered parecoxib for the management of pain after laparoscopic cholecystectomy (LC). Materials and Methods: One hundred and eight patients, American Society of Anesthesiologists I-II, were randomized to either group A ( n = 36): Lornoxicam quick-release 8 mg PO, group B ( n = 36): Parecoxib 40 mg intravenous (IV) or group C ( n = 36) placebo, for post-operative analgesia, 30 min before the operation and 12 and 24 h post-operatively. All patients received a standard dose of meperidine 1 mg/kg intramuscularly before the incision and post-operatively as rescue analgesia, when visual analog scale (VAS) pain score was P = 0.001). The average dose of meperidine administered was significantly higher in the placebo group, both at 20 min ( P = 0.013/0.007) and 24 h ( P = 0.037/0.023) post-operatively. VAS scores and meperidine requirements were similar in patients who received lornoxicam or parecoxib. Conclusions: Parecoxib 40 mg IV and lornoxicam quick-release 8 mg PO every 12 h are equivalent adjuvant analgesics with a greater efficacy than placebo for post-operative analgesia in patients undergoing LC.